Skip to main content
. Author manuscript; available in PMC: 2013 Dec 22.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2013 Aug 21;9(11):10.1517/17425255.2013.827170. doi: 10.1517/17425255.2013.827170

Figure 2. Consultation loop in the Consultation and Advice stage of a biomarker qualification process.

Figure 2

Several stages in current biomarker qualification processes throughout regulatory agencies are vulnerable to prolonged consultation cycles where applicants and reviewers go through multiple cycles of discussion about context of use and evidentiary standards for biomarker qualification.